Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment
mwooten / Pixabay

Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment

According to a story from BioPortfolio, the biopharmaceutical company X4 Pharmaceuticals, Inc. has recently initiated a phase 3 clinical trial that is testing its current lead product candidate mavorixafor. This…

Continue Reading Company Starts up Late Stage Trial Testing Experimental WHIM Syndrome Treatment

Vogmask Offers a Stylish Face Mask for Those Living with Immunodeficiencies

Vogmask is a San Francisco, California based company founded in 2011. They create stylish facial masks to protect wearers from inhalation of particulate and allergens. These types of masks can…

Continue Reading Vogmask Offers a Stylish Face Mask for Those Living with Immunodeficiencies

X4 Pharmaceuticals Reports Positive Phase 2 Results for WHIM Syndrome Drug

According to an article published by Biospace, X4 Pharmaceuticals, based in Cambridge, Massachusetts, has recently announced successful phase two results in clinical trials for their experimental drug X4P-001. The drug…

Continue Reading X4 Pharmaceuticals Reports Positive Phase 2 Results for WHIM Syndrome Drug
Experimental Treatment for WHIM Syndrome Gets Orphan Drug Designation
jarmoluk / Pixabay

Experimental Treatment for WHIM Syndrome Gets Orphan Drug Designation

According to a story from BioSpace, the biotechnology company X4 Pharmaceuticals recently announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation to the company's investigational…

Continue Reading Experimental Treatment for WHIM Syndrome Gets Orphan Drug Designation
Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV
Rainer_Maiores / Pixabay

Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV

Researchers are exploring a new diagnostic method that could be applied to newborn screening for certain inherited diseases and monitoring of HIV patients. For more detailed information, you can click…

Continue Reading Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV

Interim Results From a Study of a Potential Treatment For WHIM Syndrome Have Been Released

Clinical data from a Phase 2 study of the experimental drug X4P-001-RD for the treatment of WHIM syndrome has been announced at the European Hematology Association’s 23rdCongress in Stockholm. The…

Continue Reading Interim Results From a Study of a Potential Treatment For WHIM Syndrome Have Been Released
A Report on UK Patients with Primary Immunodeficiency Hopes to Inform Medical Professionals About the Conditions
kreatikar / Pixabay

A Report on UK Patients with Primary Immunodeficiency Hopes to Inform Medical Professionals About the Conditions

A primary immunodeficiency report, published in the journal Clinical and Experimental Immunology, examines medical care for primary immunodeficiency patients in the UK. The publication of the report coincides with the…

Continue Reading A Report on UK Patients with Primary Immunodeficiency Hopes to Inform Medical Professionals About the Conditions
Screening Test for Navajo Newborns Saves Babies Suffering from Severe Combined Immunodeficiency (SCID)
Source: Pixabay

Screening Test for Navajo Newborns Saves Babies Suffering from Severe Combined Immunodeficiency (SCID)

Joy Littlesunday is just one of many Navajo newborns who were screened and thus saved from severe combined immunodeficiency by a successful bone marrow transplant at UC San Francisco, reported UCSF…

Continue Reading Screening Test for Navajo Newborns Saves Babies Suffering from Severe Combined Immunodeficiency (SCID)

CGD News: Genetic Code Editing Makes Animal Testing More Accurate

There is a long-standing debate on the ethical ramifications of testing medical procedures and drug treatments on animals. One side argues that nothing can replace the valuable information gathered from…

Continue Reading CGD News: Genetic Code Editing Makes Animal Testing More Accurate
Countdown to Cleveland: Why Walking Can Make a Difference This Year for the PI Community
[Source: pixabay.com]

Countdown to Cleveland: Why Walking Can Make a Difference This Year for the PI Community

Primary immunodeficiency diseases (PI) are a group of more than 300 rare and chronic disorders where part of the body's immune system is missing or does not function properly. Since…

Continue Reading Countdown to Cleveland: Why Walking Can Make a Difference This Year for the PI Community
Clear Your Fall Schedule and Join a Walk for the Immunodeficiency Foundation
https://pixabay.com/en/people-autumn-walking-blur-fall-1132524/

Clear Your Fall Schedule and Join a Walk for the Immunodeficiency Foundation

When you have an immunodeficiency disease, you’re very much at risk of getting an opportunistic infection because your immune system isn’t “scanning” your body’s cells to kill off abnormal or…

Continue Reading Clear Your Fall Schedule and Join a Walk for the Immunodeficiency Foundation